Teladoc Health (TDOC) Stock
US telehealth company providing virtual visits and chronic care. Here's the price, business snapshot, and what's worth knowing about Teladoc Health in October 2026.
Teladoc Health (TDOC) is a US-based telehealth company that provides virtual medical consultations, remote monitoring and integrated chronic care management. With a market capitalisation of about $1.53 billion (as provided), Teladoc combines a large membership base, provider networks and technology platforms to sell subscription and visit-based services to employers, insurers and health systems. Investors should note the business sits at the intersection of healthcare and technology: growth is tied to broader telemedicine adoption, partnerships, and cross-selling of specialised services, while margins depend on utilisation and cost control. The company has pursued acquisitions and international expansion to diversify revenue, but it has faced pressure from competition, pricing dynamics and variable reimbursement. This summary is educational and not personalised advice — healthcare stocks can be volatile and past performance does not guarantee future returns. Consider your own risk tolerance, diversification needs and, if necessary, seek regulated financial advice.
Teladoc Health (TDOC) Stock Forecast
Analyst price target, next 12 months
$11.19
+93.0% vs today's $5.80
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Teladoc Health have a consensus 12-month target of $11.19, above the current price of $5.80.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 7 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest maintaining current investments in Teladoc with a target price of $11.19.
Financial Health
Teladoc is showing solid revenue and cash flow performance, with strong profit margins supporting growth.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Telehealth adoption rising
Virtual care usage expands the addressable market and cross‑sell opportunities, though demand can be cyclical and competition may pressure pricing.
Global expansion potential
International partnerships and acquisitions could diversify revenue streams, but regulatory differences and execution risk remain significant.
Profitability focus
Management aims for cost discipline and margin improvement; investors should note prior losses and ongoing cash‑flow considerations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
